Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2018 1
2019 1
2020 1
2021 5
2022 2
2023 4
2024 5
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
Piselli P, Tavelli A, Cimaglia C, Muccini C, Bandera A, Marchetti GC, Torti C, Mazzotta V, Pipitò L, Caioli A, Girardi E, Antinori A, Serraino D, d'Arminio Monforte A, Cingolani A; Icona Foundation Study Group. Piselli P, et al. Int J Cancer. 2025 Sep 15;157(6):1142-1153. doi: 10.1002/ijc.35493. Epub 2025 May 29. Int J Cancer. 2025. PMID: 40437996 Free PMC article.
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.
Cingolani A, Tavelli A, De Benedittis S, Mastrorosa I, Muccini C, Bini T, Carraro A, Compagno M, Mazzitelli M, Guastavigna M, Cernuschi M, Torti C, Antinori A, d'Arminio Monforte A; ICONA Foundation Study group. Cingolani A, et al. J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273. J Antimicrob Chemother. 2024. PMID: 39140512 Free PMC article.
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.
Gagliardini R, De Benedittis S, Tavelli A, Lapadula G, Mazzotta V, Bruzzesi E, Cervo A, Carrozzo G, Saracino A, Rusconi S, Marchetti G, Ceccherini-Silberstein F, Antinori A, d'Arminio Monforte A, Muccini C; Icona Foundation Study Group. Gagliardini R, et al. J Antimicrob Chemother. 2025 Aug 1;80(8):2169-2178. doi: 10.1093/jac/dkaf184. J Antimicrob Chemother. 2025. PMID: 40570134 Free PMC article.
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Salpini R, Piermatteo L, D'Anna S, Carrara S, Malagnino V, Mazzotta V, Brancaccio G, Marchetti GC, Rosselli Del Turco E, Rossotti R, Mussini C, Antinori A, Lo Caputo S, Ceccherini Silberstein F, Gaeta GB, Svicher V, Puoti M; Icona Foundation Study Group. d'Arminio Monforte A, et al. Liver Int. 2024 Feb;44(2):603-613. doi: 10.1111/liv.15804. Epub 2023 Dec 15. Liver Int. 2024. PMID: 38100128 Free article.
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort.
De Vito A, Tavelli A, Cozzi-Lepri A, Giacomelli A, Rossotti R, Ponta G, Bobbio N, Ianniello A, Cingolani A, Madeddu G, Antinori A, d'Arminio Monforte A; ICONA Foundation Study Group. De Vito A, et al. HIV Med. 2025 Jun;26(6):970-977. doi: 10.1111/hiv.70037. Epub 2025 Apr 28. HIV Med. 2025. PMID: 40296167 Free PMC article.
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort.
Vergori A, Cozzi-Lepri A, Lo Caputo S, Tavelli A, Mazzotta V, Schiaroli E, Orofino G, Mussini C, Nozza S, Cingolani A, Antinori A, d'Arminio Monforte A; Icona Foundation Study Group. Vergori A, et al. J Antimicrob Chemother. 2025 Nov 4;80(11):3082-3091. doi: 10.1093/jac/dkaf345. J Antimicrob Chemother. 2025. PMID: 40985146 Free PMC article.
A GDPR-Compliant Partner Notification Service.
Kakalou C, Polychronidou E, Drosou V, Dimitriadis VK, Dermaris T, Kordonias R, Papaprodromou A, Tsirelis T, Maramis C, Votis K, Tzovaras D, Savarino D, Maffeo M, Jasic N, Nemeth-Blažić T, Dominković Z, Pogledić D, Jovovic I, Simkunaite-Zazecke A, Stoniene L, Sammut A, Cosmaro L, Natsiavas P. Kakalou C, et al. Among authors: cosmaro l. Stud Health Technol Inform. 2022 Jan 14;289:460-464. doi: 10.3233/SHTI210957. Stud Health Technol Inform. 2022. PMID: 35062190
Scale-up of HIV self-testing.
Jakobsen SF, Raben D, Sperle I, Lazarus JV, James C, Mendão L, de Wit J, Platteau T, von Lingen AI, Corbelli GM, Antoniadi C, Casabona J, West B, Rockstroh J, Delpech V; HIV in Europe Steering Committee. Jakobsen SF, et al. HIV Med. 2018 May 8. doi: 10.1111/hiv.12618. Online ahead of print. HIV Med. 2018. PMID: 29737617 Free article. No abstract available.
Lessons learned from the first European project on the integration of infectious diseases in testing services, data collection and country responses.
Raben D, Casabona J, Cosmaro L, Gasbarrini N, Lambert JS, Glapsy S, Kakalou C, Maffeo M, Mommi M, Corradini G, Klavs I, Kurbatova A, Wawer I, Wysocki P, Raahauge A, Jakobsen SF, Lazarus JV, Sullivan A, Kall M, Hedrich D, Johnson CC, Seguy NS, Simões D, Delpech V. Raben D, et al. Among authors: cosmaro l. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):690. doi: 10.1186/s12879-021-06362-7. BMC Infect Dis. 2021. PMID: 34517824 Free PMC article. No abstract available.
25 results